Midwest Chest Consultants | Saint Charles, MO
Status and phase
Conditions
Treatments
About
This study will evaluate the efficacy and safety of astegolimab compared with placebo in participants with chronic obstructive pulmonary disease (COPD) who are former or current smokers and have a history of frequent exacerbations.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria
Exclusion Criteria
Primary purpose
Allocation
Interventional model
Masking
1,290 participants in 3 patient groups, including a placebo group
Loading...
Central trial contact
Reference Study ID Number: GB44332 https://forpatients.roche.com/
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal